baber/WOPTO huggingface dataset:
Patent NZ-570901-A (NZ)
Title: Fermented bubble drink with functionality
Inventor: KWON TAE-GOOK
IPC: A23L19/10
Filed: 2007-03-06
Abstract: Disclosed is a method for producing a fermented bubble drink comprising the steps of: Steaming, drying and roasting natural grains; Pulverizing the roasted natural grains to prepare a fine powder of roasted grains; Adding functional ingredients, such as fermented food, to the fine powder of roasted grains while maintaining the humidity of the fine powder below 5%, and pulverizing the mixture to prepare a powder having a size of 10 microns or less; Preparing a powder of a monosaccharide or oligosaccharide, having a particle size of 10 microns or less; Providing a powder or extract of raw materials selected from the group consisting of strains, inocula, microbes, vectors, bacteria, fungi, mosses, yeasts, enzymes, acids, hormones, honey, ginseng steamed red, alcoholic drinks, yogurts, and such fermented food and beverages, or mixtures thereof, to impart fermentation to a final bubble drink product; Mixing the powders prepared in the preceding steps, and mixing the resulting mixture with a liquid of bubbling agent such as milk and guar gum to prepare a food concentrate in a gel state; Agitating the food concentrate while adding liquid of bubbling agent such as milk and guar gum to convert the gel into a sol; Dropping a gas-saturated solution on the sol to generate a bubble blast; and packaging for storing the liquid and foam phases of the bubble drink in the same or separate containers.
Patent NZ-572256-A (NZ)
Title: Medical uses of antisecretory proteins for the treatment or prevention of dysfunction of lipid rafts, receptors and/or caveolae
Inventor: HANSSON HANS-ARNE
IPC: A61P7/00
Filed: 2007-04-27
Abstract: Disclosed is the use of an antisecretory protein, a functional homologue and/or fragment thereof, having equivalent activity, and/or a pharmaceutically active salt thereof, for the manufacture of a pharmaceutical composition for treatment and/or prevention of dysfunction of lipid rafts, receptors and/or caveolae in cell membranes, wherein said dysfunction is selected from the group consisting of vascular dysfunction, cardiovascular dysfunction, lung dysfunction, diabetes mellitus, diabetes mellitus related complications, hyperplasia and/or hypertrophy of cells and/or tissue, cardiomyopathy, pulmonary disorder, and tumors and complications thereof, or for facilitating improved biointegration of implanted foreign material into a mammal.
Patent NZ-577993-A (NZ)
Title: Antioxidant sensor, methods and compositions
Inventor: MCANALLEY SHAYNE
IPC: A23L33/00
Filed: 2004-08-25
Abstract: Disclosed is an antioxidant dietary supplement comprising: (a) an isolated and purified lipophobic anti-oxidant; and (b) an isolated and purified lipophilic anti-oxidant, wherein the lipophobic and the lipophilic antioxidants combined have a dissolved oxygen value of greater than 6,000 micro Mol 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (Trolox) Equivalents (TE)/gram; and wherein the ratio of (a) to (b) is between 10:90 and 90: 10 and is synergistic as measured by the ORAC(o) value being greater than the expected amount for each of (a) and (b); wherein the dietary supplement is suitable for human consumption; and wherein the lipophobic and the lipophilic anti-oxidant are mixed with or coated with a material that is resistant to enteric degradation or disintegration for a selected period of time; whereby the antioxidants are time-released. (62) Divided Out of 545231
Patent NZ-578965-A (NZ)
Title: The use of nickel and a veterinary acceptable carrier in the absence or a protein source in agriculture
Inventor: SPIERS ADRIAN
IPC: A23K1/00
Filed: 2010-08-09
Abstract: Disclosed is a method of maintaining or improving animal health, productivity and/or fertility by administering nickel to a non-human animal in a daily dose of about 0.001mg/kg/day to 1mg/kg/day by way of a trace element mineral supplement comprising nickel and a veterinary acceptable carrier, wherein the trace element mineral supplement does not contain a protein source. Further disclosed is a method of synchronising estrous and/or ovulation in a group of non-human animals by administering nickel to each animal in the group in a daily dose of about 0.01mg/kg/day to 1mg/kg/day by way of a trace element mineral supplement comprising nickel and a veterinary acceptable carrier, wherein the trace element mineral supplement does not contain a protein source. Further disclosed is a method of increasing rumen efficiency in a ruminant animal by administering nickel to a non-human animal in a daily dose of about 0.01mg/kg/day to 1mg/kg/day by way of a trace element mineral supplement comprising nickel and a veterinary acceptable carrier, wherein the trace element mineral supplement does not contain a protein source. Further disclosed is a trace element mineral supplement for maintaining or improving animal health, productivity and/or fertility comprising nickel and a veterinary acceptable carrier, wherein the trace element mineral supplement does not contain a protein source.
Patent NZ-585421-A (NZ)
Title: An apparatus for encoding using a low-density parity check code
Inventor: YOKOKAWA TAKASHI
IPC: H03M13/19
Filed: 2008-11-18
Abstract: Disclosed is an encoding apparatus for carrying out encoding by an LDPC (Low Density Parity Check) code. The apparatus is comprised of encoding means and a parity check matrix. The encoding means is configured for carrying out encoding by an LDPC code which has a code length of 64,800 bits and an encoding rate of 2/3. The parity check matrix of the LDPC code is configured such that elements of the value 1 of an information matrix are arranged in a period of every 360 columns in the column direction. The information matrix corresponds to the code length of the parity check matrix and an information length corresponding to the encoding rate, decided by a parity check matrix initial value table representative of the positions of the elements of the value 1 of the information matrix.
Patent NZ-591910-A (NZ)
Title: Personal portable power distribution apparatus
Inventor: PARTRIDGE MILES
IPC: H02J7/00
Filed: 2009-09-30
Abstract: Disclosed is a personal portable power distribution apparatus including a portable central power source, a power management module coupled to receive power from the central power source, and a harness assembly having at least one power supply node for distributing power from the power management module. The power management module is operable to control supply of power through each individual power supply node, each of which terminates in a like connector. An adaptor module is fitted to a power input terminal of an electronic accessory device to adapt the device for operation with the power distribution apparatus by providing a corresponding connector suitable for interconnection with the like connector(s). The power management module may also identify electronic devices coupled to the connectors and control characteristics of the electrical supply accordingly.
Patent NZ-596093-A (NZ)
Title: High affinity human antibodies to human il-4 receptor
Inventor: MARTIN JOEL H
IPC: A61P37/08
Filed: 2009-10-27
Abstract: Disclosed are substitutes lactam derivatives and their uses in the manufacture of a medicament for treatment of glaucoma and ocular hypertension.
Patent NZ-596720-A (NZ)
Title: CHANNEL AND WATER STORAGE LINER using ethylene vinyl acetate copolymer and cementius composition
Inventor: HANNA RUSSELL
IPC: E02B5/02
Filed: 2010-04-28
Abstract: 596720 Disclosed herein is a membrane comprising a geotextile and a flexible water impermeable cured cementitious composition disposed on at least one side of the geotextile, wherein said cured cernentitious composition comprises: a binder polymer, such as ethylene-vinyl acetate co-polymer; cement; a first filler, such as a non-reinforcing filler comprising sand; and a second filler which is different to the first filler, such as a reinforcing filled comprising calcium carbonate; the process for the production thereof; and a method for the use thereof. Additionally disclosed is the composition further comprising a third filler, such as sand, clay or a mixture thereof.
Patent NZ-597130-A (NZ)
Title: Dry decelerator for apples or like objects
Inventor: KUNZLER ALEX E
IPC: B65G11/00
Filed: 2010-07-16
Abstract: 597130 A decelerator device for apples or the like. The apples (A) are delivered to the decelerator device by a tube (12) which can be provided with either a positive pressure upstream of the transported objects or a vacuum downstream of the objects. The decelerator (10) is provided with an area of reduced pressure (R) in communication with the distal end (14) of the transport tube. A plurality of inter-engaged wheels (20, 22) receives the apples or other objects in the area of reduced pressure. The wheels receive objects between opposed sealing surfaces, at a contact area (24), reduce the traveling speed of the object, and transport the object to an area of ambient pressure (P). The sealing surfaces are disengaged from the transported objects in the area of ambient pressure, and the objects are delivered to a transport path, dry bin, or other desired structure. The wheels may be replaced by a pair of endless conveyors which engage each other, or between lobes of a single wheel, to provide an endless moveable means of receiving the apples or like objects.
Patent NZ-597500-A (NZ)
Title: Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
Inventor: WALLACE DAVID
IPC: A23L27/00
Filed: 2004-08-06
Abstract: Disclosed are arylamide compounds useful for flavour modulation in ingestible compositions. Examples of the amide compounds are: N-(heptan-4-yl)-2-methylbenzo[d] [1,3]dioxole-5-carboxamide, N-(heptan-4-yl)-6-methylbenzo[d][1,3)dioxole-5-carboxamide, (R)-methyl 4-methyl-2-(5-methylbenzofuran-2-carboxamido)pentanoate.
Patent NZ-598138-A (NZ)
Title: Synthesis of ivabradine via cyclisation of an acetal intermediate
Inventor: PEGLION JEAN-LOUIS
IPC: A61K31/55
Filed: 2012-02-09
Abstract: Disclosed is a process for the synthesis of ivabradine of formula (I): characterised in that a compound of formula (VI) wherein R1 and R2, which are the same or different, represent linear or branched alkoxy groups or together with the carbon atom carrying them form a 1,3-dioxane, 1,3-dioxolane or 1,3-dioxepane ring, is subjected to a reductive amination reaction with the compound of formula (VII), in the presence of a reducing agent, in an organic solvent, a mixture of organic solvents or a mixture of organic solvent(s) and water, to yield the compound of formula (VIII) (such as the compound N-{ [(7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl} -N'-(2,2-dimethoxyethyl)-N-methylpropane-1,3-diamine) which is subjected to a condensation reaction with the compound of formula (IX), in the presence of a base in an organic solvent, to yield the compound of formula (X) (such as N-{ 3-[{ [(7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl} -(methyl)amino]propyl} -N-(2,2-dimethoxyethyl)-2-(3,4-dimethoxyphenyl)acetamide) which is subjected to a cyclisation reaction in an acid medium to yield the compound of formula (V), which is subjected to a hydrogenation reaction to yield ivabradine of formula (I), which may optionally be converted into addition salts thereof with a pharmaceutically acceptable acid selected from hydrochloric acid, hydrobromic acid, sulphuric acid, phosphoric acid, acetic acid, trifluoroacetic acid, lactic acid, pyruvic acid, malonic acid, succinic acid, glutaric acid, fumaric acid, tartaric acid, maleic acid, citric acid, ascorbic 5 acid, oxalic acid, methanesulphonic acid, benzenesulphonic acid and camphoric acid, and into hydrates thereof.
Patent NZ-599912-A (NZ)
Title: suuport post for a safety line with an internal shock absorber
Inventor: AUSTON OLIVER
IPC: E04G21/32
Filed: 2012-05-10
Abstract: A support post assembly 10 for supporting a fall safety line 2, the support post assembly comprises a support post 12, a safety line mount 14 to which a safety line 2 may be secured, and a shock absorber 31. The support post has opposite first and second ends 33, 34 a post axis extending there between, and at the first end 33, a base portion 15 for fixing the assembly to a supporting surface. The safety line mount 14 extends away from the second end 34 of the support post. The shock absorber 31 is housed within the support post 12 between the first and second ends 33, 34 of the post, the shock absorber comprising a pivot 20 such that in the event of a fall by a worker secured to the safety line 2, lateral forces imparted to the safety line mount 14 by the fall are transmitted to the shock absorber 31 thereby causing the shock absorber to deflect laterally with respect to the post axis. The pivot 20 is connected to the base portion 15 and is located between the first and second ends 33, 34 of the support post, the shock absorber 31 having a first portion 40 and a second portion 40a, these portions being located on, respectively, opposite first and second sides 52, 52a of the pivot. The lateral deflection of the shock absorber causes at least a part of both of the first and second portions 40, 40a to rotate about the pivot 20, 22 so that both portions of the shock absorber absorb energy from the fall.
Patent NZ-602395-A (NZ)
Title: Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
Inventor: MJALLI ADNAN M M
IPC: A61K31/4168
Filed: 2011-02-10
Abstract: Disclosed are 3-methyl-2-(6-trifluoromethoxy-benzothiazol-2-ylamino)-3H-imidazo[4,5-b]pyridine-6-carboxylic acid amides, 1-methyl-2-(6-trifluoromethyl-benzothiazol-2-ylamino)-1H-benzoimidazole-5-carboxylic acid amides, 2-(6-chloro-benzothiazol-2-ylamino)-1-methyl-1H-benzoimidazole-5-carboxylic acids and their derivatives as represented by the general formula (I), wherein v is 1, R2 is selected from trifluoromethyl, trifluoromethoxy or chloro; R3 is hydrogen; R4 is selected from methyl, ethyl or 2-methoxy-ethyl; X1 is selected from CH or N; X2 is selected from CH or CF; X3 is carbon substituted with a carboxamide group as defined herein; and X4 is CH. Representative compounds include 3-methyl-2-(6-trifluoromethoxy-benzothiazol-2-ylamino)-3H-imidazo[4,5-b]pyridine-6-carboxylic acid (2-methoxy-5 ethyl)-amide, 3-methyl-2-(6-trifluoromethoxy-benzothiazol-2-ylamino)-3H-imidazo[4,5-b]pyridine-6-carboxylic acid (2-morpholin-4-yl-ethyl)-amide, 1-methyl-2-(6-trifluoromethyl-benzothiazol-2-ylamino)-1H-benzoimidazole-5-carboxylic acid (2-methoxy-ethyl)-amide, 2-(6-chloro-benzothiazol-2-ylamino)-1-methyl-1H-benzoimidazole-5-carboxylic acid (2-methoxy-ethyl)-amide, 6-fluoro-1-methyl-2-(6-trifluoromethoxy-benzothiazol-2-ylamino)-1H-benzoimidazole-5-carboxylic acid ethylamide, 1-ethyl-2-(6-trifluoromethoxy-benzothiazol-2-ylamino)-1H-benzoimidazole-5-carboxylic acid (2-ethoxy-ethyl)-amide, 1-(2-methoxy-ethyl)-2-(6-trifluoromethoxy-benzothiazol-2-ylamino)-1H-benzoimidazole-5-carboxylic acid (2-ethoxy-ethyl)-amide, 1-methyl-2-(6-trifluoromethyl-benzothiazol-2-ylamino)-1H-benzoimidazole-5-carboxylic acid [2-((S)-3-methoxy-pyrrolidin-1-yl)-2-oxo-ethyl]-amide, and 1-methyl-2-(6-trifluoromethyl-benzothiazol-2-ylamino)-1H-benzoimidazole-5-carboxylic acid ((S)-1-dimethylcarbamoyl-ethyl)-amide. Also disclosed is a pharmaceutical composition comprising a compound as defined above and a pharmaceutically acceptable carrier or diluent, for use in treating a disease, disorder, or condition selected from the group consisting of: (i) a cardiovascular disease (such as arteriosclerosis or hypertension); (ii) diabetes and diabetic-related complications, including glomerular nephropathy; (iii) a cerebral nerve degenerative disease (such as Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, or multiple sclerosis); (iv) asthma; (v) chronic obstructive pulmonary disease; (vi) a skin disease; (vii) an eye disease including macular degeneration, cataracts, light retinopathy, and retinopathy of prematurity; and (viii) cancer.
Patent NZ-603669-A (NZ)
Title: A flashing connector
Inventor: OWENS DOUGLAS CHARLES
IPC: E04D1/34
Filed: 2011-06-07
Abstract: Disclosed is a flashing connector for connecting and flanking two axially aligned z-shaped type flashing elements to provide improved weather and water protection. The flashing connector has a substantially z-shaped cross-section complementary to the cross-sectional shape of the flashing elements, such that the connector abuts and supports, at least in part, as if a shoe, an end region of each flashing element where the flashing elements are adjacent to each other. The connector substantially overlaps externally facing surfaces of each end region in use. The connector supports the end region of each flashing element in a slot. A lower portion at the end region of each flashing element is received in a slot provided at a lower edge region of the connector. The connector can connect two flashing elements that are orientated perpendicular to one another. The connector overlies a lower portion of the end region of each z flashing element. The cross-sectional shape of the connector is complementary to the cross-sectional shape of the z type flashing elements. The connector, optionally with an attached packer or attached packers, can be used to flash connect through an internal or external corner, and wherein the connector substantially overlaps externally facing surfaces of the end regions.
Patent NZ-603741-A (NZ)
Title: A housing for a wireless marker and method of use
Inventor: GIBBS RUSSELL NORMAN
IPC: G01V15/00
Filed: 2012-11-20
Abstract: 603741 Disclosed is a wireless marking device for locating underground utilities, such as cables. The wireless marking device comprises a wireless marker (8), such as an RFID tag, which has a directional response to an interrogation signal, and a housing (1), comprising a body (2) configured to house the wireless marker. The body comprises a recess (3) configured to house the end of a flexible utility line, and an elongate ground engagement member (4) extending from the body. The elongate ground engagement member is configured to be inserted into the ground to support the housing in an orientation such that the directional response is in a substantially vertical direction. A method of marking the location of an end of a flexible utility line, using the aforementioned wireless marking device, is also disclosed.
Patent NZ-610294-A (NZ)
Title: Human antibodies to human tnf-like ligand 1a (tl1a)
Inventor: CLASSON BRENDAN J
IPC: C07K16/28
Filed: 2011-11-08
Abstract: Disclosed is an isolated human antibody or antigen-binding fragment thereof that specifically binds human TNF-like ligand 1 A (hTL1A), comprising a heavy chain complementarity determining region 1 (HCDR1), HCDR2 and HCDR3 sequence combination of SEQ ID NO:20/22 and 24 or a sequence having at least 90% identity to SEQ ID NO: 24; and a light chain complementarity determining region 1 (LCDR1), LCDR2 and LCDR3 sequence combination of SEQ ID NO:28/30/32, wherein the sequences are as defined in the complete specification.
Patent NZ-613262-A (NZ)
Title: Highly penetrating compositions and methods for treating pathogen-induced disordered tissues
Inventor: JOHNSON RON B
IPC: A61K47/10
Filed: 2012-01-19
Abstract: This disclosure relates a composition for application to disordered tissue caused by a virus, bacteria, fungus or non-pathogenic toxin comprising at least one anti-infective agent comprising an organohalide, a liquid carrier comprising a tissue penetrating component and a topical anaesthetic. The organohalide may be an organochloride and more specifically may be a benzalkonium chloride. The anaesthetic may be benzocaine. The treatment composition is designed to penetrate more quickly into disordered tissue and have an increased residence time in the treatment area. The treatment compositions and methods may employ the use of an applicator. The disclosure also relates to the use of this composition for treatment of disorders caused by a virus, bacteria, fungus or non-pathogenic toxin.
Patent NZ-617119-A (NZ)
Title: Hydraulic desalination device and method
Inventor: PIERRE MARVIN
IPC: C02F103/08
Filed: 2012-03-29
Abstract: A hydraulic desalination system, device and method includes lowering the pressure of liquid saltwater to the vaporization point by generating flow through piping and accompanying infrastructure that may include valves that impart friction and control flow, capturing the vapor, condensing the vapor using higher pressure supplied by the ambient surroundings producing freshwater, recovering the heat released during condensation by maintaining ambient temperatures greater than vapor temperatures, and then using the recovered heat to enhance and perpetuate vaporization in a cyclical manner. Spring-loaded pumps (165a-165e) for pumping fluids facilitate the process.
Patent NZ-631702-A (NZ)
Title: Production of long chain polyunsaturated fatty acids in plant cells
Inventor: SINGH SURINDER PAL
IPC: C12N15/82
Filed: 2013-06-14
Abstract: Disclosed are extracted plant lipids, comprising fatty acids in an esterified form, the fatty acids comprising oleic acid, palmitic acid, omega6 fatty acids which comprise linoleic acid (LA), omega3 fatty acids which comprise alpha-linolenic acid (ALA) and docosahexaenoic acid (DHA), and optionally one or more of stearidonic acid (SDA), eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA) and eicosatetraenoic acid (ETA), wherein the level of DHA in the total fatty acid content of the extracted lipid is about 7% to 20%, and wherein the level of palmitic acid in the total fatty acid content of the extracted lipid is between about 2% and 16%, and wherein the level of myristic acid (C14:0) in the total fatty acid content of the extracted lipid is less than 1%. Further disclosed are processes for producing such lipids and plants, seeds, products or methods comprising such lipids.
Patent NZ-701947-A (NZ)
Title: Processes to produce certain 2-(pyridine-3-yl)thiazoles
Inventor: NIYAZ NOORMOHAMED M
IPC: C07D417/04
Filed: 2013-05-30
Abstract: The invention disclosed in this document is related to the field of processes to produce certain 2-(pyridine-3-yl)thiazoles as intermediates for the synthesis of pesticidal thiazole amides. Compounds (I) and (lla) are reacted to produce compound (lib). Compounds (lla) and (llb) can be in the form of a salt or free base. The reaction is conducted in the presence of a base such as tnethylamine, when compound (lla) is a salt, and the reaction is conducted in a polar protic solvent. Compounds (lib) and (llc) are reacted to produce compound (III), in a polar solvent such as an ether or an alcohol. Compound (III) is cyclized using a dehydrating agent. Examples of such dehydrating agents include, but are not limited to, POCI3, H2S04, SOCI2, P205, polyphosphoric acid, p-toluene sulfonic acid, and trifluoroacetic anhydride.
Patent NZ-703067-A (NZ)
Title: Coated sheet materials having high solar reflective index and corrosion resistance, and methods of making same
Inventor: SCHWENDEMAN IRINA G
IPC: C09D7/48
Filed: 2013-06-18
Abstract: Coated sheet materials having high solar reflective index and corrosion resistance, and methods of making such coated sheet materials, are disclosed. The coated metal sheet comprises a cured coating which comprises less than 1 weight percent of reflective pigments. In certain embodiments, the sheet materials comprise metal such as galvanized steel roofing sheets, and the coating is deposited from a latex resin.
Patent NZ-715201-A (NZ)
Title: Afucosylated anti-fgfr2iiib antibodies
Inventor: HAMBLETON JULIE
IPC: C07K16/28
Filed: 2014-07-31
Abstract: The present invention provides antibodies that bind FGFR2IIIb, wherein the antibodies are afucosylated and comprise HVR1 of TYNVH, HVR2 of SIYPDNGDTSYNQNFKG, HVR3 of GDFAY; LVR1 of KASQGVSNDVA, LVR2 of SASYRYT, and LVR3 of QQHSTTPYT. The present invention provides compositions comprising antibodies that bind FGFR2IIIb, wherein at least 95% of the antibodies in the composition are afucosylated. In some embodiments, methods of treating cancer comprising administering afucosylated anti-FGFR2IIIb antibodies are provided.